# Shanghai Xingfan Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-xingfan-biotechnology-co

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Latest round: Series A (Apr 15, 2026)
- Investors on record: 3

## About

Based in Shanghai, China and founded in 2024, Shanghai Xingfan Biotechnology Co., Ltd. is a biotechnology company focusing on new drug development, dedicated to developing clinically valuable differentiated small molecule drugs.

In April 2026, Shanghai Xingfan Biotechnology Co., Ltd. closed a round of series A funding from Tengyuan Capital, Oriza Holdings and IDG Capital.

Shanghai Xingfan Biotechnology Co., Ltd. specializes in researching and developing drugs for oncology treatment.

The company generates revenue from developing new drugs based on biopharmaceutical technology.

## Funding rounds

- Series A, Apr 15, 2026 — IDG Capital, Oriza Holdings, Tengyuan Capital

## Investors

- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series A
- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Series A
- Tengyuan Capital (https://capitalatlas.ai/funds/tengyuan-capital) — Series A